Bcl-2 and p53 expression in node-negative breast carcinoma: A study with long-term follow-up (Q58212393)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912823%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-up (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912823%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912823%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Silvio Marco Veronese

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912823%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Stephen Fox

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912823%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Claudio Eccher

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912823%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Claudio Doglioni

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912823%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Adrian Harris

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912823%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

M Barbareschi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912823%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

R D Leek

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912823%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

P Fina

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912823%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

M Bonzanini

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912823%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

S Girlando

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912823%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

L Morelli

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912823%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

F Pezzella

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912823%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

P Dalla Palma

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912823%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

language of work or name

English

0 references

publication date

1 November 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912823%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912823%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912823%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912823%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

1149-1155

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912823%20AND%20SRC:MED&resulttype=core&format=json

bcl-2 expression in normal breast tissue during the menstrual cycle

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Immunohistochemical analysis of bcl-2 and p53 expression in breast carcinomas: their correlation with Ki-67 growth fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Prognostic value of bcl-2 expression in invasive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Antibody for detecting p53 protein by immunohistochemistry in normal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

p53 as an independent prognostic marker in lymph node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Confirmation of a prognostic index in primary breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

p53 protein expression in non-neoplastic lesions and benign and malignant neoplasms of soft tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Modulation of Bcl-2 and Ki-67 expression in oestrogen receptor-positive human breast cancer by tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

An immunohistochemical study of p53 with correlations to histopathological parameters, c-erbB-2, proliferating cell nuclear antigen, and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

p53 protein expression in breast cancer as related to histopathological characteristics and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Mitosis counting in tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Histologic Grading of Breast Cancer:Let’s Do It

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Do we really need prognostic factors for breast cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

p53 status and the efficacy of cancer therapy in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

Prognosis and breast cancer. Recognition of lethal and favorable prognostic types

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990307-X

7 January 2021

10.1016/S0046-8177(96)90307-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8912823%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference